Spyre Therapeutics, Inc.

Report date
3/31/2022
Quarter
2022 Q1
Filed
5/13/2022
Shares
21,600
Value ($000)
50
Weight
0.0%
2020 Q1 - 2022 Q1 (9 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).